Lonza buys InterHealth Nutraceuticals for up to €267m
Lonza gains a suite of about 15 branded nutrients including its marquee collagen offering, UC-II.
“We are looking forward to welcoming the highly capable team to our Lonza family,” said Lonza CEO Richard Ridinger in a statement.
“They nicely complement our offerings and will be joining us in our quest to becoming the world’s leading and most-trusted supplier to the pharmaceutical, biotech and specialty ingredients markets. Lonza will be able to harness the proven management and branding capabilities and leverage them to a global level.”
The payment is split between an up-front payment and an earn-out payment.
Lonza said InterHealth – formerly owned by Kainos Capital - would continue to operate in the same premises with the same staff.
Otgher InterHealth offering include Meratrim for weight management; Relora for stress management; ChromeMate and Zychrome for blood sugar and insulin control and CardiaSlim for cholesterol management.
